18 Types of High-risk Human Papillomavirus (16/18 Typing) Nucleic Acid Detection Kit (Fluorescence P

A diagnostic test kit for the detection of human papillomavirus types 16 and 18 using PCR with fluorescence methodology. This kit is used to identify HPV infection status in clinical specimens.

This diagnostic kit uses real-time multiple fluorescent PCR technology combined with an Automated Fully Enclosed qPCR Instrument. It is used for in vitro qualitative detection of high-risk HPV16, HPV18, and 16 other high-risk types (HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV68, HPV59, HPV66, HPV73, and HPV82) in cervical exfoliated cells or reproductive tract secretions. Test results assist in HPV auxiliary diagnosis.

A fully enclosed diagnostic kit with preloaded reagents for 6-plex detection of HPV types (HPV16, HPV18, and others) using cervical exfoliated cells and genital secretion samples. The kit employs magnetic beads extraction, purification, and qPCR method with results available within 2 hours and internal control monitoring throughout the process. It requires no freezer storage or transportation.

A diagnostic kit for qualitative detection of 15 high-risk HPV E6/E7 mRNA types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) in cervical exfoliated cell samples. The kit detects HPV at the viral gene transcription level, directly reflecting the expression of HR-HPV E6/E7 oncogenic genes, and is closely associated with viral integration and cellular malignant transformation. It can serve as a risk assessment tool for cervical cancer and precancerous lesions, providing accurate information for cervical cancer screening and disease prediction.

Fluorescence PCR-based detection kit for Human Papillomavirus (HPV) identification in clinical specimens. Enables rapid, sensitive HPV genotyping for cervical cancer screening and risk stratification in diagnostic laboratories. 510(k) cleared device with fluorescence-based detection methodology.

In vitro qualitative detection kit for 15 high-risk HPV E6/E7 mRNA subtypes in cervical exfoliated cell samples. Detects HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 for cervical cancer and precancerous lesion risk assessment. NMPA Class III medical device registered.

HPV 15 genotype detection kit using fluorescence PCR melting curve analysis for identifying human papillomavirus types in clinical specimens. Enables rapid, simultaneous detection and differentiation of multiple HPV genotypes relevant to cervical cancer screening and risk stratification.

A fluorescence PCR-based qualitative detection kit for identifying 15 types of human papillomavirus DNA from cervical or urine samples. Includes CE certification and enables specific genotype differentiation.

A PCR fluorescence probe method diagnostic kit for detecting 16 high-risk human papillomavirus types and genotyping HPV 16 and 18. The kit provides 6-plex detection with internal control and is designed for use with the Galaxy Nano system.

This kit is used for qualitative detection of coronavirus OC43 RNA in human pharyngeal swab samples.

This kit is used for qualitative detection of Coxsackievirus A16, Enterovirus 71, and other enterovirus nucleic acids in children's pharyngeal swab samples.

A diagnostic test kit for the detection and quantification of hepatitis B virus using fluorescence-based quantitative PCR. This kit enables both detection and viral load assessment in clinical samples.